Disorder of hepatic
glucose metabolism is the characteristic of late-pregnant sows. The purpose of our study was to look into the mechanism of
garcinol on the improvement of hepatic gluconeogenic
enzyme in late-pregnant sows. Thirty second- and third-parity sows (Duroc × Yorkshire × Landrace, n 10/diet) were fed a basal diet (control) or that diet supplemented with 100 mg/kg (Low Gar) or 500 mg/kg (High Gar)
garcinol from day 90 of gestation to the end of farrowing. The livers were processed to measure enzymatic activity. Hepatocytes from pregnant sows were transfected with P300/CBP-associating factor (PCAF)
small interfering RNA (
siRNA) or treated with
garcinol. Dietary
garcinol had no effect on average daily feed intake,
body weight (BW), backfat and BW gain of late-pregnant sows.
Garcinol promoted plasma
glucose levels in pregnant sows and newborn piglets.
Garcinol up-regulated hepatic gluconeogenic
enzyme expression and decreased PCAF activity.
Garcinol had no effect on the expression of
PPAR-γ co-activator 1α (PGC-1α) and Forkhead box O1 (FOXO1) but significantly increased their activity and decreased their acetylation in late-pregnant sows. Transfection of PCAF
siRNA to hepatocytes of pregnant sows increased PGC-1α and FOXO1 activities. Furthermore, in hepatocytes of pregnant sows,
garcinol treatment also up-regulated the activities of PGC-1α and FOXO1 and inhibited the acetylation of PGC-1α and FOXO1.
Garcinol improves hepatic gluconeogenic
enzyme expression in late-pregnant sows, and this may be due to the mechanism of down-regulating the acetylation of PGC-1α and FOXO1 induced by PCAF in isolated hepatocytes.